Filana Therapeutics (MEX:FLNA) Cyclically Adjusted Book per Share: MXN77.82 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLNA Filana Therapeutics Inc MEX:FLNA
32 GF Score
Price MXN23.00
! 1 Warning Sign
View Full Analysis

What is Filana Therapeutics Cyclically Adjusted Book per Share?

Filana Therapeutics MEX:FLNA 32 Cyclically Adjusted Book per Share is MXN77.82 as of Jun. 2026. GuruFocus rates MEX:FLNA with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Filana Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was MXN22.976. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN77.82 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Filana Therapeutics's average Cyclically Adjusted Book Growth Rate was -8.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -2.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Filana Therapeutics was 2.40% per year. The lowest was -23.20% per year. And the median was -7.50% per year.

As of today (2026-08-02), Filana Therapeutics's current stock price is MXN23.00. Filana Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN77.82. Filana Therapeutics's Cyclically Adjusted PB Ratio of today is 0.30.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Filana Therapeutics was 0.29. The lowest was 0.00. And the median was 0.00.


Filana Therapeutics  (MEX:FLNA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Filana Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=23.00/77.82
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Filana Therapeutics was 0.29. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Filana Therapeutics Cyclically Adjusted Book per Share Related Terms


Filana Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Filana Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Filana Therapeutics Cyclically Adjusted Book per Share Chart

Filana Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.96 90.92 104.98 98.00 99.27

Filana Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.65 52.39 99.27 61.78 77.82

MEX:FLNA vs INMB, DYAI, EXOZ: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Filana Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Filana Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Filana Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Filana Therapeutics's Cyclically Adjusted PB Ratio falls into.


MEX:FLNA
32GF Score
Filana Therapeutics Inc MEX:FLNA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Filana Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=22.976/333.9520*333.9520
=22.976

Current CPI (Jun. 2026) = 333.9520.

Filana Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 59.588 241.428 82.424
201612 58.289 241.432 80.626
201703 47.761 243.801 65.422
201706 36.366 244.955 49.578
201709 31.275 246.819 42.316
201712 28.879 246.524 39.121
201803 27.135 249.554 36.312
201806 24.351 251.989 32.272
201809 21.698 252.439 28.704
201812 22.382 251.233 29.751
201903 20.901 254.202 27.458
201906 19.883 256.143 25.923
201909 20.001 256.759 26.014
201912 19.082 256.974 24.798
202003 23.545 258.115 30.463
202006 22.401 257.797 29.018
202009 20.704 260.280 26.564
202012 52.047 260.474 66.729
202103 143.661 264.877 181.125
202106 137.549 271.696 169.067
202109 137.483 274.310 167.375
202112 130.165 278.802 155.913
202203 117.928 287.504 136.980
202206 109.561 296.311 123.479
202209 99.781 296.808 112.268
202212 106.290 296.797 119.596
202303 88.079 301.836 97.451
202306 73.349 305.109 80.283
202309 64.133 307.789 69.584
202312 55.246 306.746 60.146
202403 30.161 312.332 32.249
202406 72.162 314.175 76.705
202409 68.392 315.301 72.438
202412 63.041 315.605 66.706
202503 54.045 319.799 56.437
202506 34.290 322.561 35.501
202509 30.974 324.800 31.847
202512 27.732 324.054 28.579
202603 25.436 330.213 25.724
202606 22.976 333.952 22.976

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN77.82 mean?
Filana Therapeutics (MEX:FLNA) has a Cyclically Adjusted Book per Share of MXN77.82 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Filana Therapeutics and its competitors.
Is Filana Therapeutics' Cyclically Adjusted Book per Share too high?
Filana Therapeutics' current Cyclically Adjusted Book per Share is MXN77.82. Overall, Filana Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Filana Therapeutics' Cyclically Adjusted Book per Share compare to INMB and DYAI?
Filana Therapeutics' Cyclically Adjusted Book per Share of MXN77.82 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Filana Therapeutics and its competitors. Filana Therapeutics's current Cyclically Adjusted Book per Share is MXN77.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Filana Therapeutics stock overvalued right now?
Filana Therapeutics (MEX:FLNA) has a current Cyclically Adjusted Book per Share of MXN77.82. The current Cyclically Adjusted Book per Share is MXN77.82. Filana Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Filana Therapeutics (MEX:FLNA), the current Cyclically Adjusted Book per Share is MXN77.82 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Filana Therapeutics Business Description

Other Exchanges FLNA:USAPX91:Germany
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
32GF Score

Get the complete analysis for MEX:FLNA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN23.00
Price